MedPath

A study between Magnesium sulphate and Fentanyl as additive to 0.125% Ropivacaine in Labor Epidural analgesia

Phase 3
Conditions
Health Condition 1: O- Medical and Surgical
Registration Number
CTRI/2023/02/049893
Lead Sponsor
arayana Medical College
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patient request;Primigravida;Aged >18years;ASA II;BMI <30Kg/m2

Exclusion Criteria

Patient refusal;ASA III & IV;History of coagulation disorder;Inflammatory/Infective skin lesions at the site;Any co-morbidity;BMI >30 kg/m2

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Onset of sensory block <br/ ><br>Duration of Analgesia <br/ ><br>VAS ScoreTimepoint: Basal,5 min,10min,15 min,30 min,60 min,120 min,180 min,240 min
Secondary Outcome Measures
NameTimeMethod
side effects if anyTimepoint: Basal,5 min,10 min,15 min,30 min,60 min,120 min,180 min,240 min,
© Copyright 2025. All Rights Reserved by MedPath